Literature DB >> 22057210

Symptom prevalence in the last days of life in Germany: the role of place of death.

Luis Carlos Escobar Pinzón1, Matthias Claus, Kirsten Isabel Zepf, Sabine Fischbeck, Martin Weber.   

Abstract

Investigations have shown that symptom prevalence varies according to the place of death. We sought to assess the symptom prevalence of chronically ill people in Germany and how this prevalence differs depending on the place of death. We sent questionnaires to 5000 bereaved people in Rhineland-Palatinate (Germany), whose relatives died between May 25 and August 24, 2008. In all, 3832 questionnaires were delivered and 1378 completed (response 36.0%). Most decedents had moderate-to-severe weakness (94.5%), fatigue (93.5%), need for help in daily activities (87.9%), and appetite loss (87.4%). Pain and dyspnea were most severe in hospitals; fatigue, confusion/disorientation, and problems with wound care in nursing homes; and need for help in daily activities and overburden of family at home. Associations persisted after adjusting for potential confounders.

Entities:  

Mesh:

Year:  2011        PMID: 22057210     DOI: 10.1177/1049909111425228

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  8 in total

1.  Experience of the temporary discharge from the inpatient palliative care unit: A nationwide post-bereavement survey for end-of-life cancer patients.

Authors:  Go Sekimoto; Sakiko Aso; Naoko Hayashi; Keiko Tamura; Chieko Yamamoto; Maho Aoyama; Tatsuya Morita; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita
Journal:  Asia Pac J Oncol Nurs       Date:  2022-04-11

2.  Dying with dementia: symptom burden, quality of care, and place of death.

Authors:  Luis Carlos Escobar Pinzon; Matthias Claus; Klaus Maria Perrar; Kirsten Isabel Zepf; Stephan Letzel; Martin Weber
Journal:  Dtsch Arztebl Int       Date:  2013-03-22       Impact factor: 5.594

3.  Clinical changes in terminally ill cancer patients and death within 48 h: when should we refer patients to a separate room?

Authors:  In Cheol Hwang; Hong Yup Ahn; Sang Min Park; Jae Yong Shim; Kyoung Kon Kim
Journal:  Support Care Cancer       Date:  2012-09-07       Impact factor: 3.603

4.  Choosing care homes as the least preferred place to die: a cross-national survey of public preferences in seven European countries.

Authors:  Natalia Calanzani; Katrien Moens; Joachim Cohen; Irene J Higginson; Richard Harding; Luc Deliens; Franco Toscani; Pedro L Ferreira; Claudia Bausewein; Barbara A Daveson; Marjolein Gysels; Lucas Ceulemans; Barbara Gomes
Journal:  BMC Palliat Care       Date:  2014-10-23       Impact factor: 3.234

5.  Last Year of Life Study Cologne (LYOL-C): protocol for a cross-sectional mixed methods study to examine care trajectories and transitions in the last year of life until death.

Authors:  Julia Strupp; Gloria Hanke; Nicolas Schippel; Holger Pfaff; Ute Karbach; Christian Rietz; Raymond Voltz
Journal:  BMJ Open       Date:  2018-04-17       Impact factor: 2.692

6.  Effectiveness of two types of palliative home care in cancer and non-cancer patients: A retrospective population-based study using claims data.

Authors:  Markus Krause; Bianka Ditscheid; Thomas Lehmann; Maximiliane Jansky; Ursula Marschall; Winfried Meißner; Friedemann Nauck; Ulrich Wedding; Antje Freytag
Journal:  Palliat Med       Date:  2021-06       Impact factor: 4.762

7.  Is dying in hospital better than home in incurable cancer and what factors influence this? A population-based study.

Authors:  Barbara Gomes; Natalia Calanzani; Jonathan Koffman; Irene J Higginson
Journal:  BMC Med       Date:  2015-10-09       Impact factor: 8.775

8.  Quality assurance for care of the dying: engaging with clinical services to facilitate a regional cross-sectional survey of bereaved relatives' views.

Authors:  Catriona Mayland; Tamsin McGlinchey; Maureen Gambles; Helen Mulholland; John Ellershaw
Journal:  BMC Health Serv Res       Date:  2018-10-10       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.